Exporter

You can select particular sections to be included in the output file.
EN
FR

Liste modèle des médicaments essentiels

effacer Trouvé 18 recommandations pour 12 médicaments et 13 équivalents thérapeutiques
Les recommandations supprimées et les demandes rejetées sont affichées. Les cacher.
18.5. Medicines for diabetes
  1. Beinaglutide Informations générales
    Section
    Hypoglycaemic agents
    Indications
    Therapeutic equivalent to semaglutide pour Obesity
  2. Canagliflozin Informations générales
    Section
    Oral hypoglycaemic agents
    Indications
    Therapeutic equivalent to empagliflozin pour Type 2 diabetes mellitus
  3. Dapagliflozin Informations générales
    Section
    Oral hypoglycaemic agents
    Indications
    Therapeutic equivalent to empagliflozin pour Type 2 diabetes mellitus
  4. Dulaglutide Informations générales
    Section
    Hypoglycaemic agents
    Indications
    Therapeutic equivalent to semaglutide pour Obesity Therapeutic equivalent to semaglutide pour Type 2 diabetes mellitus
  5. Empagliflozin Informations générales
    Section
    Oral hypoglycaemic agents
    • Oral > Solid: 10 mg; 25 mg
    Indications
    Type 2 diabetes mellitus
  6. Exenatide Informations générales
    Section
    Hypoglycaemic agents
    Indications
    Therapeutic equivalent to semaglutide pour Obesity
  7. Glibenclamide Informations générales
    Section
    Oral hypoglycaemic agents
    • Oral > Solid: 5 mg; 2.5 mg
    Indications
    Type 2 diabetes mellitus
  8. Gliclazide Informations générales
    Section
    Oral hypoglycaemic agents
    • Oral > Solid: 30 mg controlled-release; 60 mg controlled-release; 80 mg controlled-release
    Indications
    Type 2 diabetes mellitus
  9. Insulin (analogue, long-acting) Informations générales
    Section
    Insulins
    • Parenteral > General injections > SC: 100 IU per mL in 3 mL cartridge solution; 100 IU per mL in 3 mL pre-filled pen solution; 100 IU per mL in 10 mL vial solution
    Indications
    Type 2 diabetes mellitus Type 1 diabetes mellitus
  10. Insulin (analogue, rapid-acting) Informations générales
    Section
    Insulins
    • Parenteral > General injections > SC: 100 IU per 1 mL in 10 mL vial; 100 IU per 1 mL in 3 mL cartridge; 100 IU per 1 mL in 3 mL pre-filled pen
    Indications
    Type 1 diabetes mellitus Type 2 diabetes mellitus
  11. Insulin (human, intermediate-acting) Informations générales
    Section
    Insulins
    • Parenteral > General injections > SC: 40 IU per mL in 10 mL vial as compound insulin zinc suspension or isophane insulin; 100 IU per mL in 10 mL vial as compound insulin zinc suspension or isophane insulin; 100 IU per mL in 3 mL cartridge as compound insulin zinc suspension or isophane insulin; 100 IU per mL in 3 mL pre-filled pen as compound insulin zinc suspension or isophane insulin
    Indications
    Type 2 diabetes mellitus Type 1 diabetes mellitus
  12. Insulin (human, short-acting) Informations générales
    Section
    Insulins
    • Parenteral > General injections > SC: 40 IU per mL in 10 mL vial solution; 100 IU per mL in 10 mL vial solution; 100 IU per mL in 3 mL cartridge solution; 100 IU per mL in 3 mL pre-filled pen solution
    Indications
    Type 2 diabetes mellitus Type 1 diabetes mellitus
  13. Insulin analogues Informations générales
    Section
    Insulins
    • Not specified
    Indications
    Type 1 diabetes mellitus Type 2 diabetes mellitus
  14. Insulin aspart Informations générales
    Section
    Insulins
    • Parenteral > General injections > SC: 100 IU per mL in 110 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen
    • Parenteral > General injections > SC: 100 IU per mL in 10 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen
    Indications
    Therapeutic equivalent to insulin (analogue, rapid-acting) pour Type 1 diabetes mellitus Therapeutic equivalent to insulin (analogue, rapid-acting) pour Type 2 diabetes mellitus
  15. Insulin degludec Informations générales
    Section
    Insulins
    • Parenteral > General injections > SC: 100 units per mL
    Indications
    Therapeutic equivalent to insulin glargine pour Type 1 diabetes mellitus Therapeutic equivalent to insulin (analogue, long-acting) pour Type 2 diabetes mellitus Therapeutic equivalent to insulin (analogue, long-acting) pour Type 1 diabetes mellitus
  16. Insulin detemir Informations générales
    Section
    Insulins
    Indications
    Therapeutic equivalent to insulin glargine pour Type 1 diabetes mellitus Therapeutic equivalent to insulin (analogue, long-acting) pour Type 2 diabetes mellitus Therapeutic equivalent to insulin (analogue, long-acting) pour Type 1 diabetes mellitus
  17. Insulin glargine Informations générales
    Section
    Insulins
    • Parenteral > General injections > SC: 100 units per mL
    Indications
    Type 1 diabetes mellitus Therapeutic equivalent to insulin (analogue, long-acting) pour Type 2 diabetes mellitus Therapeutic equivalent to insulin (analogue, long-acting) pour Type 1 diabetes mellitus
  18. Insulin glulisine Informations générales
    Section
    Insulins
    • Parenteral > General injections > SC: 100 IU per mL in 10 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen
    Indications
    Therapeutic equivalent to insulin (analogue, rapid-acting) pour Type 1 diabetes mellitus Therapeutic equivalent to insulin (analogue, rapid-acting) pour Type 2 diabetes mellitus
  19. Insulin lispro Informations générales
    Section
    Insulins
    • Parenteral > General injections > SC: 100 IU per mL in 10 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen
    Indications
    Therapeutic equivalent to insulin (analogue, rapid-acting) pour Type 1 diabetes mellitus Therapeutic equivalent to insulin (analogue, rapid-acting) pour Type 2 diabetes mellitus
  20. Liraglutide Informations générales
    Section
    Hypoglycaemic agents
    Indications
    Therapeutic equivalent to semaglutide pour Obesity Therapeutic equivalent to semaglutide pour Type 2 diabetes mellitus
  21. Metformin Informations générales
    Section
    Oral hypoglycaemic agents
    • Oral > Solid: 500 mg (hydrochloride)
    Indications
    Type 2 diabetes mellitus
  22. Semaglutide Informations générales
    Section
    Hypoglycaemic agents
    • Parenteral > General injections > SC: 0.25 mg in pre-filled pen injection solution; 0.5 mg in pre-filled pen injection solution; 1 mg in pre-filled pen injection solution; 2 mg in pre-filled pen injection solution; 4 mg in pre-filled pen injection solution
    • Oral > Solid > tablet: 3 mg
    • Parenteral > General injections > SC: 0.68 mg per mL; 1.34 mg per mL; 2.68 mg per mL
    Indications
    Obesity Type 2 diabetes mellitus
  23. Tirzepatide Informations générales
    Section
    Hypoglycaemic agents
    Indications
    Therapeutic equivalent to semaglutide pour Obesity Therapeutic equivalent to semaglutide pour Type 2 diabetes mellitus
  24. Tolbutamide Informations générales
    Section
    Oral hypoglycaemic agents
    • Oral > Solid: 500 mg
    Indications
    Type 2 diabetes mellitus